290.13
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$295.43
Aprire:
$296.16
Volume 24 ore:
2.63M
Relative Volume:
1.20
Capitalizzazione di mercato:
$156.19B
Reddito:
$34.76B
Utile/perdita netta:
$6.62B
Rapporto P/E:
23.74
EPS:
12.223
Flusso di cassa netto:
$10.61B
1 W Prestazione:
-2.60%
1M Prestazione:
+4.17%
6M Prestazione:
+3.10%
1 anno Prestazione:
-9.62%
Amgen Inc Stock (AMGN) Company Profile
Nome
Amgen Inc
Settore
Industria
Telefono
(805)447-1000
Indirizzo
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA
Confronta AMGN con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
AMGN
Amgen Inc
|
290.13 | 159.05B | 34.76B | 6.62B | 10.61B | 12.22 |
![]()
LLY
Lilly Eli Co
|
833.49 | 766.78B | 53.26B | 13.80B | -50.20M | 15.08 |
![]()
JNJ
Johnson Johnson
|
190.72 | 460.19B | 90.62B | 22.66B | 18.18B | 9.35 |
![]()
ABBV
Abbvie Inc
|
230.50 | 407.53B | 58.33B | 3.73B | 18.24B | 2.1013 |
![]()
NVS
Novartis Ag Adr
|
130.03 | 253.71B | 53.40B | 13.68B | 16.89B | 6.8864 |
![]()
MRK
Merck Co Inc
|
85.99 | 218.56B | 63.43B | 16.42B | 14.72B | 6.4861 |
Amgen Inc Stock (AMGN) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-09-03 | Ripresa | Raymond James | Mkt Perform |
2025-05-20 | Ripresa | Guggenheim | Neutral |
2025-04-22 | Ripresa | Cantor Fitzgerald | Neutral |
2024-12-10 | Ripresa | BofA Securities | Underperform |
2024-11-15 | Iniziato | Wolfe Research | Peer Perform |
2024-11-14 | Iniziato | Citigroup | Neutral |
2024-10-17 | Iniziato | Bernstein | Outperform |
2024-10-14 | Downgrade | Truist | Buy → Hold |
2024-09-27 | Iniziato | Cantor Fitzgerald | Overweight |
2024-08-07 | Downgrade | Wells Fargo | Overweight → Equal Weight |
2024-05-03 | Aggiornamento | Barclays | Underweight → Equal Weight |
2024-05-03 | Aggiornamento | William Blair | Mkt Perform → Outperform |
2024-03-28 | Ripresa | Raymond James | Mkt Perform |
2024-02-07 | Downgrade | Leerink Partners | Outperform → Market Perform |
2023-12-21 | Aggiornamento | Daiwa Securities | Neutral → Buy |
2023-12-19 | Aggiornamento | BMO Capital Markets | Market Perform → Outperform |
2023-12-12 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
2023-11-09 | Iniziato | Deutsche Bank | Hold |
2023-11-02 | Aggiornamento | Truist | Hold → Buy |
2023-10-20 | Ripresa | JP Morgan | Neutral |
2023-10-17 | Ripresa | Morgan Stanley | Equal-Weight |
2023-10-11 | Ripresa | BofA Securities | Neutral |
2023-09-06 | Iniziato | HSBC Securities | Buy |
2023-04-24 | Reiterato | Oppenheimer | Outperform |
2023-03-13 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
2023-02-13 | Reiterato | Truist | Buy |
2022-11-18 | Iniziato | Credit Suisse | Underperform |
2022-10-31 | Downgrade | Barclays | Equal Weight → Underweight |
2022-10-11 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
2022-05-23 | Iniziato | SVB Leerink | Mkt Perform |
2022-02-09 | Reiterato | Barclays | Equal Weight |
2022-02-09 | Reiterato | Jefferies | Buy |
2022-02-09 | Reiterato | Morgan Stanley | Equal-Weight |
2022-02-09 | Reiterato | Oppenheimer | Outperform |
2022-02-09 | Reiterato | Wells Fargo | Equal Weight |
2022-01-05 | Downgrade | BofA Securities | Buy → Neutral |
2021-12-09 | Ripresa | Wells Fargo | Equal Weight |
2021-12-06 | Iniziato | Goldman | Buy |
2021-11-19 | Iniziato | BMO Capital Markets | Market Perform |
2021-09-23 | Downgrade | Daiwa Securities | Outperform → Neutral |
2021-09-07 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
2020-12-29 | Iniziato | Daiwa Securities | Buy |
2020-10-28 | Iniziato | UBS | Neutral |
2020-10-26 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
2020-10-12 | Aggiornamento | Truist | Hold → Buy |
2020-10-09 | Downgrade | Bernstein | Outperform → Mkt Perform |
2020-10-09 | Downgrade | Truist | Buy → Hold |
2020-10-08 | Downgrade | Raymond James | Outperform → Mkt Perform |
2020-04-15 | Ripresa | Guggenheim | Neutral |
2020-03-31 | Iniziato | Wolfe Research | Peer Perform |
2020-03-30 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
2020-03-05 | Aggiornamento | BofA/Merrill | Neutral → Buy |
2020-02-27 | Iniziato | Barclays | Equal Weight |
2020-01-31 | Downgrade | Robert W. Baird | Neutral → Underperform |
2020-01-21 | Aggiornamento | Evercore ISI | In-line → Outperform |
2019-12-24 | Iniziato | Raymond James | Mkt Perform |
2019-12-17 | Ripresa | Morgan Stanley | Overweight |
2019-11-12 | Iniziato | SunTrust | Buy |
2019-11-05 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
2019-10-17 | Ripresa | BofA/Merrill | Neutral |
2019-08-19 | Downgrade | Mizuho | Buy → Neutral |
2019-05-23 | Aggiornamento | Citigroup | Neutral → Buy |
Mostra tutto
Amgen Inc Borsa (AMGN) Ultime notizie
AbbVie And Amgen's Blueprint To Digitalize Biomanufacturing - Bioprocess Online
Market reaction to Amgen Inc.’s recent newsMarket Risk Summary & Technical Confirmation Alerts - newser.com
Quantitative breakdown of Amgen Inc. recent moveMarket Weekly Review & Daily Risk Controlled Trade Plans - newser.com
Is Amgen Inc. (AMG0) stock cheap by valuation metricsTrade Volume Summary & Verified Chart Pattern Trade Signals - newser.com
Will Amgen Inc. (AMG0) stock outperform energy sector in 20252025 Winners & Losers & AI Driven Stock Reports - newser.com
Will Amgen Inc. (AMG0) stock benefit from mergersJuly 2025 Momentum & Risk Controlled Swing Trade Alerts - newser.com
Mainstay Capital Management LLC ADV Increases Position in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Stake Boosted by Copperwynd Financial LLC - MarketBeat
What moving averages say about Amgen Inc.July 2025 Sector Moves & Weekly Chart Analysis and Trade Guides - newser.com
US Bancorp DE Has $198.15 Million Stock Holdings in Amgen Inc. $AMGN - MarketBeat
Insight Inv LLC Has $2.10 Million Position in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Sold by Columbus Macro LLC - MarketBeat
Amgen Inc. $AMGN Shares Purchased by Callan Family Office LLC - MarketBeat
Trifecta Capital Advisors LLC Boosts Position in Amgen Inc. $AMGN - MarketBeat
Here's What to Expect From Amgen’s Next Earnings Report - Yahoo Finance
Will Amgen Inc. stock deliver better than expected guidance2025 Earnings Impact & Short-Term Trading Opportunity Alerts - newser.com
How to forecast Amgen Inc. trends using time seriesEarnings Miss & Advanced Technical Signal Analysis - newser.com
Meet Olusope Otuyelu, a 2025 40 Under 40 honoree - The Business Journals
Maryland State Retirement & Pension System Has $7.30 Million Holdings in Amgen Inc. $AMGN - MarketBeat
Massachusetts Wealth Management Takes $1.82 Million Position in Amgen Inc. $AMGN - MarketBeat
First Merchants Corp Has $2.91 Million Stock Position in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Holdings Lowered by Sitrin Capital Management LLC - MarketBeat
Narwhal Capital Management Sells 3,886 Shares of Amgen Inc. $AMGN - MarketBeat
How Amgen Inc. (AMGN) Affects Rotational Strategy Timing - news.stocktradersdaily.com
(AMGN) Price Dynamics and Execution-Aware Positioning - news.stocktradersdaily.com
Amgen (NASDAQ:AMGN) Stock Rating Upgraded by Weiss Ratings - MarketBeat
Amgen Launches New Direct-To-Consumer Platform - Pharmaceutical Executive
(AMGN) Movement Within Algorithmic Entry Frameworks - news.stocktradersdaily.com
Trading the Move, Not the Narrative: (AMGN) Edition - news.stocktradersdaily.com
Gene Therapy Market Size to Worth USD 58.87 Billion Rising at 20% CAGR by 2034 | Towards Healthcare - GlobeNewswire Inc.
Is Trending Stock Amgen Inc. (AMGN) a Buy Now? - Yahoo Finance
Dohj LLC Grows Stock Position in Amgen Inc. $AMGN - MarketBeat
Castle Rock Wealth Management LLC Acquires 2,931 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN is WoodTrust Financial Corp's Largest Position - MarketBeat
Avoiding Lag: Real-Time Signals in (AMGN) Movement - news.stocktradersdaily.com
BankPlus Trust Department Raises Stock Position in Amgen Inc. $AMGN - MarketBeat
Shell Asset Management Co. Acquires 7,440 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Receives Consensus Rating of "Hold" from Analysts - MarketBeat
The Technical Signals Behind (AMGN) That Institutions Follow - news.stocktradersdaily.com
(AMGN) and the Role of Price-Sensitive Allocations - news.stocktradersdaily.com
Here's What To Expect From Amgen’s Next Earnings Report - Barchart.com
Biotechnology Market Therapeutic Innovations & Forecast Report 2025-2033 Featuring Lonza, Amgen, Syn - PharmiWeb.com
Amgen Unveils New DTC Program, Cuts Cholesterol Drug Price by 60% - Yahoo Finance
(AMGN) as a Liquidity Pulse for Institutional Tactics - news.stocktradersdaily.com
Amgen identifies new GTPase KRAS mutant inhibitors - BioWorld MedTech
Biotechnology Market Therapeutic Innovations & Forecast Report 2025-2033 Featuring Lonza, Amgen, Syngenta, Biocon, Biogen, F. Hoffmann-La Roche, Novartis, Novo Nordisk A/S, Pfizer, and SeagenResearchAndMarkets.com | FinancialContent - FinancialContent
Amgen price collects profitsForecast today07-10-2025 - Economies.com
Amgen Inc. $AMGN Shares Acquired by Godsey & Gibb Inc. - MarketBeat
Amgen Inc. $AMGN Shares Sold by Country Club Bank - MarketBeat
KLP Kapitalforvaltning AS Buys 8,500 Shares of Amgen Inc. $AMGN - MarketBeat
Simplicity Wealth LLC Has $1.43 Million Holdings in Amgen Inc. $AMGN - MarketBeat
Amgen Inc Azioni (AMGN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):